• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Researchers discover the science behind giving up

Bioengineer by Bioengineer
July 25, 2019
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study published in Cell reveals activity of nociceptin neurons

IMAGE

Credit: Max Hunter

What happens when we give up?

Inside the brain, a group of cells known as nociceptin neurons get very active before a mouse’s breakpoint. They emit nociceptin, a complex molecule that suppresses dopamine, a chemical largely associated with motivation.

The findings, reported July 25 in Cell, offer new insight into the complex world of motivation and reward.

The nociceptin neurons are located near an area of the brain known as the ventral tegmental area. The VTA contains neurons that release dopamine during pleasurable activities. Although scientists have previously studied the effects of fast, simple neurotransmitters on dopamine neurons, this study is among the first to describe the effects of this complex nociception modulatory system.

“We are taking an entirely new angle on an area of the brain known as VTA,” said co-lead author Christian Pedersen, a fourth-year Ph.D. student in bioengineering at the University of Washington School of Medicine and the UW College of Engineering.

Researchers at the UW School of Medicine and at Washington University School of Medicine as well as colleagues at other universities, spent four years looking at the role of nociceptin in regulating motivation.

“The big discovery is that large complex neurotransmitters known as neuropeptides have a very robust effect on animal behavior by acting on the VTA,” said Pedersen.

The researchers said this discovery could lead to helping people find motivation when they are depressed and conversely decrease motivation for drugs in substance- abuse disorders, like addiction.

The discovery came by looking at the neurons in mice seeking sucrose. The mice had to poke their snout into a port to get sucrose. At first it was easy, then it became two pokes, then five, increasing exponentially, and so on. Eventually, all the mice gave up. Neural activity recordings revealed that these “demotivation” or “frustration” neurons became most active when mice stopped seeking sucrose.

In mammals, the neural circuits that underlie reward seeking are regulated by mechanisms to keep homeostasis – the tendency to maintain internal stability to compensate for environmental changes. In the wild, animals are less motivated to seek rewards in environments where resources are scarce. Persistence in seeking uncertain rewards can be disadvantageous due to risky exposure to predators or from energy expenditure, the researchers noted.

Deficits within these regulatory processes in humans can manifest as behavioral dysfunctions, including depression, addiction, and eating disorders.

Senior author Michael Bruchas, professor of anesthesiology and pain medicine and of pharmacology at the University of Washington School of Medicine is one of the principal faculty in UW’s new Center for Neurobiology of Addiction, Pain, and Emotion. He said the findings could go a long way into finding help for patients whose motivation neurons are not functioning correctly.

“We might think of different scenarios where people aren’t motivated like depression and block these neurons and receptors to help them feel better,” he said. “That’s what’s powerful about discovering these cells. Neuropsychiatric diseases that impact motivation could be improved.”

Looking to the future, he said, these neurons could perhaps be modified in people seeking drugs or those that have other addictions.

###

Media Contact
Bobbi Nodell
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.cell.2019.06.034

Tags: AddictionDepression/AngerPharmaceutical ScienceSocial/Behavioral Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Innovative 3D Printing Technique ‘Grows’ Ultra-Strong Materials

October 8, 2025
blank

Birds Flourish Despite Pollution from Persistent ‘Forever’ Chemicals

October 8, 2025

Rice University Unveils Second Cohort of Chevron Energy Graduate Fellows

October 7, 2025

Covalent Organic Frameworks: Building Infinite Metal–Organic Structures

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1073 shares
    Share 429 Tweet 268
  • New Study Reveals the Science Behind Exercise and Weight Loss

    100 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    79 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unveiling the Plant Sulfotransferase Family’s Evolution

Impact of Artery Ligation Level in Colon Cancer

Examining Healthcare Provider Letters in Court Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.